As Herceptin Goes Off Patent, 'Biosimilars' Emerge

13-12-2013 MedscapeComments (0)

Biosimilars

They belong to a product category known as biosimilars, which reflects their contents, explained Charles Zacharchuk, MD, PhD, development lead at Pfizer Worldwide Research and Development. Generics are chemically synthesized small-molecule drugs.

Read more on Medscape

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top